There are some first-line chemotherapeutic combination regimens for the treatment of advanced GC, including Trastuzumab-based regimes for HER2-positive cases, fluoropyrimidine-based regimens, and platinum-based regimens (Wang FH. The gene discussed is ERBB2; the disease is gastric cancer.